4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-022904
EVP & Chief R & QA Officer sold 22,400 shares at $40.07 ($897,568)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Clark Mitchall G. EVP & Chief R & QA Officer | 2018-03-29 | Sale | −22,400 | $40.07 | $897,568 | 133,671 | D |
| Open-market sales · 22,400 sh · avg $40.07 · $897,568 | |||||||
Loading xslF345X03/doc4.xml…